Hermann, Julia https://orcid.org/0009-0001-8545-4698
Borteçen, Toman
Kalis, Robert https://orcid.org/0000-0001-7553-4806
Kowar, Alexander https://orcid.org/0000-0002-7868-3935
Pechincha, Catarina https://orcid.org/0000-0002-4650-4250
Vogt, Vivien
Schneider, Martin
Helm, Dominic https://orcid.org/0000-0001-9321-2069
Krijgsveld, Jeroen
Loayza-Puch, Fabricio https://orcid.org/0000-0002-2999-8594
Zuber, Johannes https://orcid.org/0000-0001-8810-6835
Palm, Wilhelm https://orcid.org/0000-0003-0612-770X
Article History
Received: 15 January 2024
Accepted: 14 April 2025
First Online: 6 May 2025
Competing interests
: J.Z. is a founder, shareholder and scientific advisor of Quantro Therapeutics. J.Z. and the Zuber lab receive research support and funding from Boehringer Ingelheim. Other authors declare no competing interests.